SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : STEM -- StemCells, Inc. -- Ignore unavailable to you. Want to Upgrade?


To: C Wright who wrote (188)1/23/1999 2:40:00 PM
From: Mike McFarland  Respond to of 805
 
We had a little subthread going on ctii
going this morning over on another thread--
it starts here:

techstocks.com
"Diabetes-related treatment costs exceed $100 billion annually"

any feedback from this thread much appreciated.

--Mike



To: C Wright who wrote (188)1/23/1999 6:52:00 PM
From: Mike McFarland  Read Replies (2) | Respond to of 805
 
Does anyone know if there is a possible partnership
with GNE in the works?


check out post 168

what I have are two ctii/gne deals--still preclinical:

amyotrophic lateral sclerosis (ALS)
Marketer(s): Genentech (Hoffmann-La Roche)
cell line releasing Neurotrophin-4/5

and
amyotrophic lateral sclerosis (ALS)
Marketer(s): Genentech (Hoffmann-La Roche)
cell line releasing cardiotrophin-1

The Parkinson's deal has been off for awhile.

regards,
Mike